These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9930854)
1. HIV-1 neutralizing antibodies: how full is the bottle? Moore JP; Burton DR Nat Med; 1999 Feb; 5(2):142-4. PubMed ID: 9930854 [No Abstract] [Full Text] [Related]
2. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses. Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096 [TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. Mascola JR; Sambor A; Beaudry K; Santra S; Welcher B; Louder MK; Vancott TC; Huang Y; Chakrabarti BK; Kong WP; Yang ZY; Xu L; Montefiori DC; Nabel GJ; Letvin NL J Virol; 2005 Jan; 79(2):771-9. PubMed ID: 15613305 [TBL] [Abstract][Full Text] [Related]
4. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. Hone DM; DeVico AL; Fouts TR; Onyabe DY; Agwale SM; Wambebe CO; Blattner WA; Gallo RC; Lewis GK J Hum Virol; 2002; 5(1):17-23. PubMed ID: 12352264 [TBL] [Abstract][Full Text] [Related]
5. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Bower JF; Green TD; Ross TM Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849 [TBL] [Abstract][Full Text] [Related]
6. Immunodominant antigenic sites in primate immunodeficiency viruses and in vivo protection. Norrby E; Putkonen P; Albert J; Fenyö EM Biotechnol Ther; 1991; 2(1-2):21-9. PubMed ID: 1668984 [No Abstract] [Full Text] [Related]
7. Cowpox Helped Against Smallpox; Will the Goat Lentivirus (Caprine Arthritis Encephalitis Virus) Help Against HIV-1? Chebloune Y; Moussa M; Arrode-Brusés G; Gagnon J AIDS Res Hum Retroviruses; 2015 Jun; 31(6):577-8. PubMed ID: 25844817 [No Abstract] [Full Text] [Related]
8. AIDS vaccine development in primate models. Almond NM; Heeney JL AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994 [No Abstract] [Full Text] [Related]
9. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111 [TBL] [Abstract][Full Text] [Related]
11. Antigen presentation and related immunological aspects of HIV-1 vaccines. Steinman RM; Germain RN AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991 [No Abstract] [Full Text] [Related]
12. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110 [TBL] [Abstract][Full Text] [Related]
13. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin. Rasmussen RA; Montefiori DC; Robinson HL; McClure HM; Ruprecht RM J Infect Dis; 2001 Dec; 184(12):1603-7. PubMed ID: 11740737 [TBL] [Abstract][Full Text] [Related]
14. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype. Pal R; Kalyanaraman VS; Nair BC; Whitney S; Keen T; Hocker L; Hudacik L; Rose N; Mboudjeka I; Shen S; Wu-Chou TH; Montefiori D; Mascola J; Markham P; Lu S Virology; 2006 May; 348(2):341-53. PubMed ID: 16460776 [TBL] [Abstract][Full Text] [Related]
15. Serological responses to candidate AIDS vaccines. Graham BS AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S145-8. PubMed ID: 7865290 [No Abstract] [Full Text] [Related]
16. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P). Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906 [TBL] [Abstract][Full Text] [Related]
17. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868 [TBL] [Abstract][Full Text] [Related]
18. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles. Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793 [TBL] [Abstract][Full Text] [Related]
19. The status of HIV/AIDS vaccines--1993. Weber J Ther Immunol; 1994 Apr; 1(2):95-100. PubMed ID: 7584488 [No Abstract] [Full Text] [Related]
20. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]